Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000556689 | SCV000640500 | uncertain significance | Nemaline myopathy 2 | 2022-10-04 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 3745 of the NEB protein (p.Arg3745Leu). This variant is present in population databases (rs765379397, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 465435). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003129893 | SCV003810214 | uncertain significance | not provided | 2023-08-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003129893 | SCV004170669 | uncertain significance | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV005027642 | SCV005650443 | uncertain significance | Nemaline myopathy 2; Arthrogryposis multiplex congenita 6 | 2024-03-16 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000556689 | SCV002077088 | uncertain significance | Nemaline myopathy 2 | 2019-11-11 | no assertion criteria provided | clinical testing |